Tech Company Financing Transactions
Ikonisys Funding Round
Ikonisys, operating out of New Haven, received $30 million in funding from Goldman Sachs, New Science Ventures and Palisade Capital Management.
Transaction Overview
Company Name
Announced On
10/17/2007
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series E
Investors
Proceeds Purpose
Company CEO Dr. Petros Tsipouras said, "The additional capital provides Ikonisys with the support necessary to fulfill upcoming clinical milestones and further the development and launch of new proprietary tests within our oncoFISH and fastFISH product lines for the diagnosis and management of cancer and for women's health applications."
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5 Science Park
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
Ikonisys pioneering technology and laboratory testing offers cancer diagnosis based on rare cancer cell detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Michael Kilpatrick
VP - Operations
William Kochiss
Browse more venture capital transactions:
Prev: 10/17/2007: The Climate Corporation venture capital transaction
Next: 10/18/2007: Vocalocity venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs